News: 50 Cent & Forest Whitaker To Remake Classic Horror Film

Thursday, May 14, 2009 7:20AM

Written by Cyrus Langhorne

50 Cent and Forest Whitaker have been chosen to star in the upcoming movie remake Jekyll and Hyde.

The film is set to reportedly re-vamp the original film's setting.

Director Abel Ferrara is taking another walk on the wild side with a re-imagining of Robert Louis Stevenson's The Strange Case of Dr. Jekyll and Mr. Hyde, which will be contemporized and titled Jekyll and Hyde. Forest Whitaker and Curtis "50 Cent" Jackson are attached to play the lead roles in the classic tale about a doctor who invents a potion that unleashes his violent alter ego. (Variety)

Executive producer Luc Roeg has expressed his anticipation for the movie's final product.

"The combination of such formidable talent in front of and behind the camera will turn this wonderful gothic story into a modern classic for a whole new generation," Roeg said in a statement. (Statement)

Violator's Chris Lighty will also take part in the film.

The Ferrara-project will be produced by Glasshouse Pictures' Brett Walsh (who produced the recent James Franco/Sienna Miller flick Camille) and Cheetah Vision Films' Randall Emmett, who has worked with '50 Cent' on Righteous Kill and Streets of Blood. Sean Walsh, Bonnie Timmermann and Chris Lighty also receive executive producer credits. (Movie Hole)

Fif was recently selected to star in the upcoming film Twelve.

The movie will star Chace Crawford, Emma Roberts, Rory Culkin, Curtis "50 Cent" Jackson, Ellen Barkin and Kiefer Sutherland. The film centers on a former high schooler and drug dealer whose life takes a drastic turn after his best friend is arrested for murdering the dealer's cousin. Jordan Melamed wrote the screenplay. Production begins April 20 in New York. (Screening Log)

A release date for Jekyll & Hyde has not yet been announced.

[For more on your favorite rappers from the Big Apple peep SOHH NYC]

For the latest gadgets, gear and giveaways, check out GetFrush.com.

blog comments powered by Disqus